169 related articles for article (PubMed ID: 1390239)
1. Mixed phenotype of blasts in acute megakaryocytic leukaemia and transient abnormal myelopoiesis in Down's syndrome.
Yumura-Yagi K; Hara J; Kurahashi H; Nishiura T; Kaneyama Y; Osugi Y; Sakata N; Inoue M; Tawa A; Okada S
Br J Haematol; 1992 Aug; 81(4):520-5. PubMed ID: 1390239
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
Langebrake C; Creutzig U; Reinhardt D
Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
[TBL] [Abstract][Full Text] [Related]
3. Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype.
Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang HY; Chen W
Cytometry B Clin Cytom; 2015; 88(4):244-52. PubMed ID: 25361478
[TBL] [Abstract][Full Text] [Related]
4. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study.
Brouwer N; Matarraz S; Nierkens S; Hofmans M; Nováková M; da Costa ES; Fernandez P; Bras AE; de Mello FV; Mejstrikova E; Philippé J; Grigore GE; Pedreira CE; van Dongen JJM; Orfao A; van der Velden VHJ; On Behalf Of The EuroFlow Consortium
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326734
[TBL] [Abstract][Full Text] [Related]
6. Microarray transcript profiling distinguishes the transient from the acute type of megakaryoblastic leukaemia (M7) in Down's syndrome, revealing PRAME as a specific discriminating marker.
McElwaine S; Mulligan C; Groet J; Spinelli M; Rinaldi A; Denyer G; Mensah A; Cavani S; Baldo C; Dagna-Bricarelli F; Hann I; Basso G; Cotter FE; Nizetic D
Br J Haematol; 2004 Jun; 125(6):729-42. PubMed ID: 15180862
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic characteristics of acute megakaryocytic leukemia and transient abnormal myelopoiesis.
Yumura-Yagi K; Hara J; Tawa A; Kawa-Ha K
Leuk Lymphoma; 1994 May; 13(5-6):393-400. PubMed ID: 8069184
[TBL] [Abstract][Full Text] [Related]
8. PRAME immunohistochemical staining in transient abnormal myelopoiesis and myeloid leukemia associated with Down syndrome.
Chisholm KM; Rivetta CV; Heerema-McKenney A
Ann Clin Lab Sci; 2015; 45(2):121-7. PubMed ID: 25887863
[TBL] [Abstract][Full Text] [Related]
9. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
Karandikar NJ; Aquino DB; McKenna RW; Kroft SH
Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066
[TBL] [Abstract][Full Text] [Related]
10. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
11. Aberrant progenitors common to megakaryocytic and myeloid cells in a Down's infant with transient abnormal myelopoiesis.
Sato A; Imaizumi M; Noro T; Ichinohasama R; Saito T; Yoshinari M; Suwabe N; Suzuki H; Koizumi Y; Cui Y
Leuk Res; 1995 Nov; 19(11):811-5. PubMed ID: 8551797
[TBL] [Abstract][Full Text] [Related]
12. Down's syndrome and acute leukemia in children: an analysis of phenotype by use of monoclonal antibodies and electron microscopic platelet peroxidase reaction.
Kojima S; Matsuyama T; Sato T; Horibe K; Konishi S; Tsuchida M; Hayashi Y; Kigasawa H; Akiyama Y; Okamura J
Blood; 1990 Dec; 76(11):2348-53. PubMed ID: 2147864
[TBL] [Abstract][Full Text] [Related]
13. Transient abnormal myelopoiesis in Down's syndrome.
Kurahashi H; Hara J; Yumura-Yagi K; Tawa A; Kawa-Ha K
Leuk Lymphoma; 1992 Dec; 8(6):465-75. PubMed ID: 1297480
[TBL] [Abstract][Full Text] [Related]
14. Acute megakaryoblastic leukaemia (AMKL) in children: a comparison of AMKL with and without Down syndrome.
Hama A; Yagasaki H; Takahashi Y; Nishio N; Muramatsu H; Yoshida N; Tanaka M; Hidaka H; Watanabe N; Yoshimi A; Matsumoto K; Kudo K; Kato K; Horibe K; Kojima S
Br J Haematol; 2008 Mar; 140(5):552-61. PubMed ID: 18275433
[TBL] [Abstract][Full Text] [Related]
15. Down's Syndrome-Transient Abnormal Myelopoiesis and Acute Leukaemia.
Bain B
Leuk Lymphoma; 1991; 3(5-6):309-17. PubMed ID: 27467421
[TBL] [Abstract][Full Text] [Related]
16. Pan myeloid antigen-negative pediatric acute megakaryoblastic leukemia.
Cetin N; Lorsbach RB
Pediatr Blood Cancer; 2014 Nov; 61(11):2089-91. PubMed ID: 24962432
[TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders.
Shimada A; Hayashi Y; Ogasawara M; Park MJ; Katoh M; Minakami H; Kitoh T; Kojima S; Kawa K; Kimura H
Leuk Res; 2007 Sep; 31(9):1199-203. PubMed ID: 17055049
[TBL] [Abstract][Full Text] [Related]
18. Cell surface phenotyping of megakaryoblasts.
Koike T; Aoki S; Maruyama S; Narita M; Ishizuka T; Imanaka H; Adachi T; Maeda H; Shibata A
Blood; 1987 Mar; 69(3):957-60. PubMed ID: 3028539
[TBL] [Abstract][Full Text] [Related]
19. Expression of erythroid-specific genes in acute megakaryoblastic leukaemia and transient myeloproliferative disorder in Down's syndrome.
Ito E; Kasai M; Hayashi Y; Toki T; Arai K; Yokoyama S; Kato K; Tachibana N; Yamamoto M; Yokoyama M
Br J Haematol; 1995 Jul; 90(3):607-14. PubMed ID: 7647001
[TBL] [Abstract][Full Text] [Related]
20. The landscape of somatic mutations in Down syndrome-related myeloid disorders.
Yoshida K; Toki T; Okuno Y; Kanezaki R; Shiraishi Y; Sato-Otsubo A; Sanada M; Park MJ; Terui K; Suzuki H; Kon A; Nagata Y; Sato Y; Wang R; Shiba N; Chiba K; Tanaka H; Hama A; Muramatsu H; Hasegawa D; Nakamura K; Kanegane H; Tsukamoto K; Adachi S; Kawakami K; Kato K; Nishimura R; Izraeli S; Hayashi Y; Miyano S; Kojima S; Ito E; Ogawa S
Nat Genet; 2013 Nov; 45(11):1293-9. PubMed ID: 24056718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]